Armandi, Angelo
Merizian, Talal
Werner, Merle Marie
Coxson, Harvey O.
Sanavia, Tiziana
Birolo, Giovanni
Gashaw, Isabella
Ertle, Judith
Michel, Maurice
Galle, Peter R.
Labenz, Christian
Emrich, Tilman
Schattenberg, Jörn M. http://orcid.org/0000-0002-4224-4703
Funding for this research was provided by:
Boehringer Ingelheim
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 11 July 2023
Accepted: 11 October 2023
First Online: 12 December 2023
Declarations
:
: Institutional Review Board approval was obtained, and the study protocol was approved by the ethics committee of the Landesärztekammer Rheinland-Pfalz Nr. 873.199.10 (7208). The study was conducted according to the ethical guidelines of the 1975 Declaration of Helsinki (6th revision, 2008). All patients gave informed consent to participate in this study.
: Not applicable.
: JMS: consultant—Astra Zeneca, Apollo Endosurgery, Bayer, Boehringer Ingelheim, BMS, Gilead Sciences, GSK, Intercept Pharmaceuticals, Ipsen, Inventiva Pharma, Madrigal, MSD, Northsea Therapeutics, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, and Siemens Healthineers; research funding—Gilead Sciences, Boehringer Ingelheim, and Siemens Healthcare GmbH; stock options—AGED diagnostics and Hepta Bio; speaker honorarium—Boehringer Ingelheim, Echosens, MedPublico GmbH, Novo Nordisk, Madrigal Pharmaceuticals, Histoindex, and MedPublico GmbH.HC, IG, and JE are employees of Boehringer Ingelheim.TE is a member of the <i>European Radiology Experimental</i> Scientific Editorial Board. He has not taken part in the review or selection process of this article.